Latest Institutional Transactions on Rubius Therapeutics, Inc. (RUBY)

RUBY Quotes by TradingView

This table provides information on the latest institutional transactions involving Rubius Therapeutics, Inc. (RUBY) stock. The table includes the name of the institution, the type of operation (buy or sell), whether options were involved, the number of shares exchanged, the range of values for the transaction, and the number of shares held by the institution after the transaction has occurred.

Report Date Institution (Fund) Operation Option Shares change Value Range Shares Held Trade History
Oct 10, 2024 Q3 2024
Concourse Financial Group Securities, Inc.

Birmingham, AL
BUY
 -
0
New
N/A
0 $0
Q1 2023
Jul 17, 2024 Q1 2023
Kelly Financial Services LLC

Braintree, MA
SELL
 -
-100
Closed
$2 - $34
0 $0
May 15, 2023 Q1 2023
State Street Corp

Boston, MA
SELL
 -
-148K
Closed
$2.96K - $50.2K
0 $0
May 15, 2023 Q1 2023
Baader Bank Aktiengesellschaft

Unterschleissheim, 2M
BUY
 -
73.4K
New
$1.47K - $25K
73.4K $0
May 11, 2023 Q1 2023
Acadian Asset Management LLC

Boston, MA
SELL
 -
-1.1M
- 85.93%
$22K - $373K
180K $0
Apr 27, 2023 Q1 2023
Simplex Trading, LLC

BUY
 -
3.86K
New
$77.1 - $1.31K
3.86K $0
Q4 2022
May 14, 2024 Q4 2022
Goldman Sachs Group Inc

New York, NY
SELL
 -
-27K
- 60.67%
$3.78K - $8.37K
17.5K $0
Feb 15, 2023 Q4 2022
Virtu Financial LLC

New York, NY
BUY
 -
41.3K
+ 150.39%
$5.79K - $12.8K
68.8K $0
Feb 15, 2023 Q4 2022
Steward Partners Investment Advisory, LLC

BUY
 -
200
New
$28 - $62
200 $0
Feb 14, 2023 Q4 2022
Israel Englander Millennium Management LLC | New York, Ny
SELL
 -
-55.2K
- 24.56%
$7.73K - $17.1K
170K $0
Feb 14, 2023 Q4 2022
Bank Of New York Mellon Corp

New York, NY
BUY
 -
21K
New
$2.94K - $6.51K
21K $0
Feb 14, 2023 Q4 2022
Ergoteles LLC

New York, NY
BUY
 -
57.7K
New
$8.08K - $17.9K
57.7K $0
Feb 14, 2023 Q4 2022
Ken Griffin Citadel Advisors LLC | Chicago, Il
BUY
 PUT
600
New
$84 - $186
600 $0
Feb 14, 2023 Q4 2022
Two Sigma Investments, LP

New York, NY
BUY
 -
19.2K
New
$2.69K - $5.95K
19.2K $0
Feb 14, 2023 Q4 2022
Ken Griffin Citadel Advisors LLC | Chicago, Il
SELL
 -
-9.46K
- 6.67%
$1.32K - $2.93K
132K $0
Feb 14, 2023 Q4 2022
Royal Bank Of Canada

Toronto, A6
SELL
 -
-456
- 99.35%
$63.8 - $141
3 $0
Feb 13, 2023 Q4 2022
Wells Fargo & Company

San Francisco, CA
BUY
 -
8
+ 2.61%
$1.12 - $2.48
314 $0
Feb 13, 2023 Q4 2022
Black Rock Inc.

New York, NY
SELL
 -
-390K
- 24.59%
$54.7K - $121K
1.2M $0
Feb 13, 2023 Q4 2022
Geode Capital Management, LLC

Boston, MA
SELL
 -
-23.4K
- 5.38%
$3.28K - $7.26K
412K $0
Feb 13, 2023 Q4 2022
Northern Trust Corp

Chicago, IL
SELL
 -
-127
- 0.18%
$17.8 - $39.4
71.4K $0
Feb 13, 2023 Q4 2022
Jim Simons Renaissance Technologies LLC | New York, Ny
BUY
 -
71.6K
+ 55.68%
$10K - $22.2K
200K $0
Feb 13, 2023 Q4 2022
Jpmorgan Chase & CO

New York, NY
SELL
 -
-3.56K
- 61.86%
$499 - $1.1K
2.2K $0
Feb 10, 2023 Q4 2022
Tower Research Capital LLC (Trc)

New York, NY
SELL
 -
-16.5K
- 99.85%
$2.31K - $5.12K
25 $0
Feb 10, 2023 Q4 2022
Bank Of America Corp

Charlotte, NC
BUY
 -
16.1K
+ 501.37%
$2.25K - $4.98K
19.3K $0
Feb 10, 2023 Q4 2022
Vanguard Group Inc

Valley Forge, PA
SELL
 -
-28.6K
- 1.68%
$4.01K - $8.87K
1.68M $0
Feb 10, 2023 Q4 2022
Advisor Group Holdings, Inc.

Phoenix, AZ
BUY
 -
325
New
$45.5 - $101
325 $0
Feb 10, 2023 Q4 2022
New York Life Investment Management LLC

New York, NY
BUY
 -
10.9K
+ 11.94%
$1.53K - $3.38K
102K $0
Feb 09, 2023 Q4 2022
Group One Trading, L.P.

Chicago, IL
SELL
 -
-1
- 0.01%
$0.14 - $0.31
9.92K $0
Feb 09, 2023 Q4 2022
Citigroup Inc

BUY
 -
56
+ 4.35%
$7.84 - $17.4
1.34K $0
Feb 08, 2023 Q4 2022
Ubs Group Ag

BUY
 -
60.7K
+ 506.22%
$8.49K - $18.8K
72.7K $0
Feb 07, 2023 Q4 2022
Lpl Financial LLC

Fort Mill, SC
SELL
 -
-17K
- 30.18%
$2.38K - $5.27K
39.3K $0
Feb 03, 2023 Q4 2022
New England Capital Financial Advisors LLC

Meriden, CT
BUY
 -
1.11K
New
$155 - $343
1.11K $0
Jan 25, 2023 Q4 2022
Clarius Group, LLC

Seattle, WA
SELL
 -
-1.28K
- 5.65%
$179 - $397
21.4K $0
Jan 24, 2023 Q4 2022
Baillie Gifford & CO

BUY
 -
15.4K
+ 0.32%
$2.15K - $4.76K
4.87M $0
Q3 2022
Nov 15, 2022 Q3 2022
Jacobs Levy Equity Management, Inc

Florham Park, NJ
BUY
 -
544K
New
$250K - $702K
544K $0
Nov 14, 2022 Q3 2022
Jane Street Group, LLC

New York, NY
SELL
 -
-42.3K
- 64.03%
$19.5K - $54.6K
23.8K $0
Nov 14, 2022 Q3 2022
Occudo Quantitative Strategies LP

Fort Lauderdale, FL
SELL
 -
-924
- 4.42%
$425 - $1.19K
20K $0
Nov 14, 2022 Q3 2022
Cubist Systematic Strategies, LLC

Stamford, CT
SELL
 -
-62.8K
- 77.46%
$28.9K - $81K
18.3K $0
Nov 14, 2022 Q3 2022
Artal Group S.A.

Luxembourg, N4
SELL
 -
-1.66M
- 44.82%
$763K - $2.14M
2.04M $0
Nov 14, 2022 Q3 2022
Abbot Financial Management, Inc.

North Andover, MA
SELL
 -
-956K
- 67.88%
$440K - $1.23M
452K $0
Nov 14, 2022 Q3 2022
Hrt Financial LP

New York, NY
SELL
 -
-268K
- 92.91%
$123K - $345K
20.4K $0
Nov 14, 2022 Q3 2022
Schonfeld Strategic Advisors LLC

New York, NY
SELL
 -
-600
- 3.82%
$276 - $774
15.1K $0
Nov 14, 2022 Q3 2022
Gsa Capital Partners LLP

London, X0
SELL
 -
-82.7K
- 42.61%
$38K - $107K
111K $0
Nov 14, 2022 Q3 2022
Vanguard Personalized Indexing Management, LLC

Oakland, CA
BUY
 -
10.8K
New
$4.95K - $13.9K
10.8K $0
Nov 14, 2022 Q3 2022
Qube Research & Technologies LTD

London, X0
SELL
 -
-846
- 2.17%
$389 - $1.09K
38.2K $0
Nov 14, 2022 Q3 2022
Man Group PLC

London, X0
BUY
 -
13K
+ 71.54%
$5.97K - $16.8K
31.1K $0
Nov 14, 2022 Q3 2022
Cornercap Investment Counsel Inc

Atlanta, GA
BUY
 -
191K
+ 291.71%
$87.8K - $246K
256K $0
Nov 14, 2022 Q3 2022
Two Sigma Securities, LLC

New York, NY
BUY
 -
31.8K
New
$14.7K - $41.1K
31.8K $0
Nov 14, 2022 Q3 2022
Susquehanna International Group, LLP

Bala Cynwyd, PA
BUY
 -
50.9K
+ 110.24%
$23.4K - $65.6K
97K $0

Track Institutional and Insider Activities on RUBY

Follow Rubius Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RUBY shares.

Notify only if

Insider Trading

Get notified when an Rubius Therapeutics, Inc. insider buys or sells RUBY shares.

Notify only if

News

Receive news related to Rubius Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RUBY